Role of the rabbit whole-heart model for electrophysiologic safety pharmacology of non-cardiovascular drugs
- PMID: 33200170
- DOI: 10.1093/europace/euaa288
Role of the rabbit whole-heart model for electrophysiologic safety pharmacology of non-cardiovascular drugs
Abstract
Plenty of non-cardiovascular drugs alter cardiac electrophysiology and may ultimately lead to life-threatening arrhythmias. In clinical practice, measuring the QT interval as a marker for the repolarization period is the most common tool to assess the electrophysiologic safety of drugs. However, the sole measurement of the QT interval may be insufficient to determine the proarrhythmic risk of non-cardiovascular agents. Several other markers are considered in pre-clinical safety testing to determine potential harm on cardiac electrophysiology. Besides measuring typical electrophysiologic parameters such as repolarization duration, whole-heart models allow the determination of potential predictors for proarrhythmia. Spatial and temporal heterogeneity as well as changes of shape of the action potential can be easily assessed. In addition, provocation manoeuvers (either by electrolyte imbalances or programmed pacing protocols) may induce sustained arrhythmias and thereby determine ventricular vulnerability to arrhythmias. Compared with the human heart, the rabbit heart possesses a similar distribution of ion currents that govern cardiac repolarization, resulting in a rectangular action potential configuration in both species. In addition, similar biophysical properties of rabbit and human cardiac ion channels lead to a comparable pharmacologic response in human and rabbit hearts. Of note, arrhythmia patterns resemble in both species due to the similar effective size of human and rabbit hearts. Thus, the rabbit heart is particularly suitable for testing the electrophysiologic safety of drugs. Several experimental setups have been developed for studying cardiac electrophysiology in rabbits, ranging from single cell to tissue preparations, whole-heart setups, and in vivo models.
Keywords: Electrophysiological safety; Drug safety; Langendorff; Long QT syndrome; Pharmacology; QT interval; Rabbit; Torsade de pointes; Whole-heart model.
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.
Similar articles
-
Assessment of efficacy of proarrhythmia biomarkers in isolated rabbit hearts with attenuated repolarization reserve.J Cardiovasc Pharmacol. 2014 Sep;64(3):266-76. doi: 10.1097/FJC.0000000000000116. J Cardiovasc Pharmacol. 2014. PMID: 24887684
-
Severe proarrhythmic potential of risperidone compared to quetiapine in an experimental whole-heart model of proarrhythmia.Naunyn Schmiedebergs Arch Pharmacol. 2016 Oct;389(10):1073-80. doi: 10.1007/s00210-016-1274-y. Epub 2016 Jul 12. Naunyn Schmiedebergs Arch Pharmacol. 2016. PMID: 27405774
-
Beat-by-beat QT interval variability, but not QT prolongation per se, predicts drug-induced torsades de pointes in the anaesthetised methoxamine-sensitized rabbit.J Pharmacol Toxicol Methods. 2011 Jan-Feb;63(1):40-6. doi: 10.1016/j.vascn.2010.04.010. Epub 2010 May 6. J Pharmacol Toxicol Methods. 2011. PMID: 20451633
-
[Ventricular arrhythmias. A potential risk associated with the use of non-cardiovascular drugs prolonging the QT interval].Minerva Med. 2002 Jun;93(3):181-97. Minerva Med. 2002. PMID: 12094149 Review. Italian.
-
In vivo measurement of QT prolongation, dispersion and arrhythmogenesis: application to the preclinical cardiovascular safety pharmacology of a new chemical entity.Fundam Clin Pharmacol. 2002 Apr;16(2):125-40. doi: 10.1046/j.1472-8206.2002.00081.x. Fundam Clin Pharmacol. 2002. PMID: 12031065 Review.
Cited by
-
Spotlight on the 2022 ESC guideline management of ventricular arrhythmias and prevention of sudden cardiac death: 10 novel key aspects.Europace. 2023 May 19;25(5):euad091. doi: 10.1093/europace/euad091. Europace. 2023. PMID: 37102266 Free PMC article. Review.
-
Safe electrophysiologic profile of dexmedetomidine in different experimental arrhythmia models.Sci Rep. 2021 Dec 14;11(1):23940. doi: 10.1038/s41598-021-03364-y. Sci Rep. 2021. PMID: 34907251 Free PMC article.
-
Divergent electrophysiologic action of dapagliflozin and empagliflozin on ventricular and atrial tachyarrhythmias in isolated rabbit hearts.Front Cardiovasc Med. 2024 Feb 22;11:1369250. doi: 10.3389/fcvm.2024.1369250. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 38455723 Free PMC article.
-
Knock-in Kcnh2 rabbit model of long QT syndrome type-2, epilepsy, and sudden death.J Transl Med. 2025 Apr 15;23(1):446. doi: 10.1186/s12967-025-06382-w. J Transl Med. 2025. PMID: 40234944 Free PMC article.
-
More than 30 years of Brugada syndrome: a critical appraisal of achievements and open issues.Herzschrittmacherther Elektrophysiol. 2024 Mar;35(1):9-18. doi: 10.1007/s00399-023-00983-y. Epub 2023 Dec 12. Herzschrittmacherther Elektrophysiol. 2024. PMID: 38085327 Review. English.
MeSH terms
LinkOut - more resources
Full Text Sources